Innovations in cancer drug research
Access to new medicines is not high up the list of priorities for NHS England, but pharma must seize opportunities to promote innovation uptake.
Latest innovations emerging from immunotherapy research
Collaborate with CROs and sites to help minimize risks
The implications for global pharma HQs and what the UK needs to do.